Release of amphotericin B from delivery systems and its action against fungal and mammalian cells

Journal of Drug Targeting

Volumn 4, Issue 5, 1997, Pages 311-319

  Legrand, P ^a,b   Cheron M ^a   Leroy, L ^a   Bolard, J ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIV PARIS SUD   (France)

Author keywords

Amphotericin B; Antifungal activity; Candida albicans; Delivery systems; Liposomes; Release

Indexed keywords

AMPHOTERICIN B; CYCLODEXTRIN; LIPOSOME;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

EID: 0030960235     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869708995847     Document Type: Article

References (25)

1. Adler-Moore, J. P. and Proffitt, R. T. (1993) Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res., 3, 429-450.
2. Beggs, W E. (1994) Physicochemical cell damage in relation to lethal amphotericin B action. Antimicrob. Ag. Chemother., 38, 363-364.
3. Bolard, J., Legrand, P, Heitz, F. and Cybulska, B. (1991) One sided action of amphotericin B on cholesterol-containing membranes is determined by its self association in the medium. Biochem., 30, 5707-5715.
4. Brajtburg, J., Elberg, S., Kobayashi, G. S. and Medoff, G. (1994) Amphotericin B incorporated into egg lecithin-bile salt Mixed Micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycosis. Antimicrob. Ag. Chemother., 38, 300-306.
5. Chopra, R., Blair, S., Strang, J., Cervi, P., Patterson, K. G. and Goldstone, A H. (1991) Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J. Antimicrob. Chemother., 28, 93-104.
6. Janknegt, R., de Marie, S., Bakker-Woudenberg, I. A. J. M. and Crommelin, D. J. A. (1992) Liposomal and lipid formulations of amphotericin B: Clinical pharmacokinetics. Clin. Pharmacokin., 23, 279-291.
7. Joly, V., Bolard, J., Saint-Julien, L., Carbon, C. and Yeni, P. (1992) Influence of the phospholipid/amphotericin B ratio and the phospholipid type on the in vitro renal cell toxicity and fungicidal activity of lipid associated-amphotericin B formulations. Antimicrob Ag. Chemother, 36, 262-266.
8. Juliano, R. L., Grant, C. W. M., Barber, K R. and Kalp, N. A. (1987) Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol Pharmacol., 31, 1-11.
9. Jullien, S., Contrepois, A., Sligh, J. E., Domart, Y., Yeni, P. Brajtburg, J., Medoff, G. and Bolard, J. (1989) Study of the effect of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans and erythocytes by using small unilamellar vesicles prepared from saturated phospholipids. Antimicrob. Ag. Chemother, 33, 345-349
10. Jullien, S., Brajtburg, J. and Bolard, J. (1990) Affinity of amphotericin B for phosphatidyleholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. Biochim. Biophys. Acta, 1201, 39-45
11. Lambing, H. E., Wolf, B. D. and Hartsel, S C. (1993) Temperature effect on the aggregation state and activity of amphotericin B. Biochim. Biophys. Acta, 1152, 185-188
12. Legrand, P., Romero, E. A., Cohen, B. E. and Bolard, J. (1992) Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob. Ag. Chemother., 36, 2518-2522.
13. Litchfield, J T. and Wilcoxon, F. (1948) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Techn., 96, 99-113.
14. Lopez-Berestein, G., Bodey, G. P., Fainstein, V., Keating, M., Frankel, L. S., Zeluff, B., Gentry, L and Mehta, K. (1989) Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med., 149, 2533-2536.
15. Mazerski, J., Bolard, J. and Borowski, E. (1982) Self-association of some polyene macrolide antibiotic in aqueous media. Biochim. Biophys. Acta, 719, 11-17
16. Mehta, R. L., Lopez-Berestein, G., Hopfer, R., Mills, K. and Juliano, R. L. (1984) Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim. Biophys. Acta, 770, 230-234.
17. Pahls, S. and Schaffner, A. (1994) Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. J. Inf. Dis, 169, 1057-1061.
18. Perkins, W. R., Minchey, S. R., Boni, L. T., Swenson, C. E., Popescu, M. C., Pasternack, R F. and Janoff, A. S. (1992) Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity Biochim. Biophys. Acta, 1107, 271-282.
19. Rajagopalan, N., C S. C., and Chow, W. S. (1986) A study of the inclusion complex of amphotericin B with gamma.-Cyclodextrin. Int. J. Pharm., 29, 161-168.
20. Ralf, E. D., Khazindar, A. M., Barber, K. R. and Grant, C. W. M. (1991) Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves. Antimicrob. Ag. Chemother., 35, 188-191.
21. Sculier, J P., Coune, A., Meunier, F., Brassine, C., Laduron, C., Hollaert, C., Colette, N., Heymans, C. and Klatersky, J. (1988) Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections Eur. J. Cancer Clin. Oncol., 24, 527-538.
22. Stainmesse, S., Fessi, H., Devissaguet, J-P. and Puisieux, F. (1989) European patent no 894018571.
23. Szoka, F C , Milholland, D., Barza, M. (1987) Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B Antimicrob. Ag. Chemother., 31, 421-429.
24. van Etten, E. W. M., Kate, M T., Stearne, L. E. T. and Bakker-Woudenberg, I. A. J. M. (1995) Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity and efficacy in systemic candidiasis in leukopenic mice. Antimicrob. Ag. Chemother., 39, 1954-1958.
25. Witzke, N. M. and Bittman, R. (1984) Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphtidylcholine/sterol vesicles. Biochem., 23, 1668-1674.